Offer - Urjas Oil for just ₹ 1 X
Redemide 50 Capsule is a prescription drug, available for use as Capsule. It is typically used for the treatment of Multiple Myeloma. The alternative uses of Redemide 50 Capsule have also been explained below.
Medical history of the patient along with age and gender determines the dosage of Redemide 50 Capsule. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Redemide 50 Capsule as well, which are listed below. Normally, these side effects of Redemide 50 Capsule are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Redemide 50 Capsule's effect during pregnancy is Severe and Unknown while nursing. In addition, Redemide 50 Capsule's effects on the liver, heart and kidney are discussed below in the Redemide 50 Capsule related warnings section.
Redemide 50 Capsule can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Redemide 50 Capsule in conditions like Bleeding, Gastrointestinal Bleeding. Other contraindications of Redemide 50 Capsule have been discussed in the sections ahead.
Drug interactions for Redemide 50 Capsule have been reported in the medical literature. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Redemide 50 Capsule is considered not safe while driving, and is not addictive.
Redemide 50 Capsule is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
Is the use of Redemide 50 Capsule safe for pregnant women?
Pregnant women may get severe side effects after taking Redemide. If you are pregnant, do not take Redemide without a doctor's advice.
Is the use of Redemide 50 Capsule safe during breastfeeding?
No research work has been carried out till date on effect of Redemide on breastfeeding women. So it is not known whether taking Redemide will cause side effects or not.
What is the effect of Redemide 50 Capsule on the Kidneys?
Redemide rarely harms the kidneys.
What is the effect of Redemide 50 Capsule on the Liver?
Very few cases of side effects of Redemide on the liver have been reported.
What is the effect of Redemide 50 Capsule on the Heart?
Redemide may cause harmful effects on the heart. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
If you are suffering from any of the following diseases, you should not take Redemide 50 Capsule unless your doctor advises you to do so -
Is this Redemide 50 Capsule habit forming or addictive?
No, there is no any evidence that Redemide 50 Capsule is addictive.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Redemide 50 Capsule as you may feel sleepy.
Is it safe?
Redemide 50 Capsule should be used only after doctor's advice.
Is it able to treat mental disorders?
No, Redemide 50 Capsule is not used to treat mental disorders.
Interaction between Food and Redemide 50 Capsule
There isn't any research available on the side effects of taking Redemide 50 Capsule with food.
Interaction between Alcohol and Redemide 50 Capsule
Information about the interaction of Redemide 50 Capsule and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Thalomid® (thalidomide)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 786
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1195-1198